Functional Cures and the Eradication of HIV will for the first time bring together an interdisciplinary group of basic and applied scientists working on various aspects of HIV treatment and eradication strategies in an effort to translate our current understanding of HIV biology into a meaningful therapeutic and/or eradication of HIV from infected individuals. To accomplish this goal the conference will aim to: (1) introduce the state of the art in vaccine and neutralizing antibody strategies used to combat HIV; (2) focus on transcriptional control and modulation of viral latency; and (3) highlight synthetic biological approaches and genetic therapies currently being developed and clinically validated to combat HIV infection

The 2019 HIV Vaccines conference will present the latest results from human clinical studies of candidate vaccines as well as the use of monoclonal antibodies for prevention; novel HIV neutralizing antibodies and their developmental pathways; T cell functions in killing and B cell help; structural insights and immunogen design; and the intersection of research for HIV eradication/cure with research on HIV vaccines, including interventions after very early antiretroviral therapy.

AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments of novel therapeutics and immune-restorative approaches.

Pick up your copy of this groundbreaking Journal at the HIV Keystone Symposia